Published in Mol Cell Biol on June 01, 1991
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J (1997) 6.36
Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol (1991) 4.42
Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. Proc Natl Acad Sci U S A (1992) 3.25
Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J (1994) 2.33
Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J (1994) 2.32
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med (1993) 2.23
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J (1996) 2.11
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci U S A (1994) 2.09
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol (1994) 2.00
Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J (1996) 1.98
Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc Natl Acad Sci U S A (1995) 1.96
Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc Natl Acad Sci U S A (1994) 1.57
TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci U S A (1991) 1.53
TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol (1998) 1.49
Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell (2012) 1.43
An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J (1997) 1.43
Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci U S A (1994) 1.42
Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol Cell Biol (1999) 1.38
Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells. Mol Cell Biol (1996) 1.35
Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1. Mol Cell Biol (1993) 1.28
The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc Natl Acad Sci U S A (1994) 1.27
mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol (2000) 1.24
Chromatin immunoselection defines a TAL-1 target gene. EMBO J (1998) 1.22
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts. Mol Cell Biol (2000) 1.22
Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood (2006) 1.17
Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J Exp Med (1999) 1.16
Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc Natl Acad Sci U S A (1994) 1.15
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J Exp Med (2013) 1.14
BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes. Mol Cell Biol (1996) 1.12
Myocardial activation of the human cardiac alpha-actin promoter by helix-loop-helix proteins. Proc Natl Acad Sci U S A (1992) 1.11
Helix-loop-helix transcription factors E12 and E47 are not essential for skeletal or cardiac myogenesis, erythropoiesis, chondrogenesis, or neurogenesis. Proc Natl Acad Sci U S A (1992) 1.11
The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci U S A (2000) 1.08
NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. J Exp Med (2010) 1.06
E proteins and the regulation of early lymphocyte development. Immunol Rev (2010) 1.05
HEN1 and HEN2: a subgroup of basic helix-loop-helix genes that are coexpressed in a human neuroblastoma. Proc Natl Acad Sci U S A (1992) 1.04
Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J (1995) 0.96
HEN1 encodes a 20-kilodalton phosphoprotein that binds an extended E-box motif as a homodimer. Mol Cell Biol (1994) 0.95
The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. Mol Cell Biol (1998) 0.93
OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1. Cancer Res (2005) 0.92
Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines. J Virol (1996) 0.88
Different domains regulate the human erythropoietin receptor gene transcription. Nucleic Acids Res (1994) 0.87
Interactions of HTF4 with E-box motifs in the long terminal repeat of human immunodeficiency virus type 1. J Virol (1992) 0.86
A third tal-1 promoter is specifically used in human T cell leukemias. J Exp Med (1992) 0.86
Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade. Mol Cell Biol (1997) 0.85
Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts. Biochem J (1999) 0.81
N-Myc and SP regulate phosphatidylserine synthase-1 expression in brain and glial cells. J Biol Chem (2010) 0.77
Expression of a chimeric helix-loop-helix gene, Id-SCL, in K562 human leukemic cells is associated with nuclear segmentation. Am J Pathol (1992) 0.77
Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Leukemia (2016) 0.75
SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression. Sci Rep (2017) 0.75
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 22.17
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 9.73
Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science (1990) 9.54
Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell (1989) 8.42
The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell (1990) 7.94
Sequence-specific DNA binding by the c-Myc protein. Science (1990) 7.75
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (1987) 7.63
MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell (1989) 6.94
The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev (1990) 6.88
A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J (1989) 6.37
TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev (1990) 6.00
A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev (1989) 5.91
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 4.93
Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev (1989) 4.50
The achaete-scute gene complex of D. melanogaster: conserved domains in a subset of genes required for neurogenesis and their homology to myc. Cell (1987) 4.43
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A (1989) 4.22
daughterless, a Drosophila gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaete-scute complex. Cell (1988) 3.94
Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev (1990) 3.44
Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc Natl Acad Sci U S A (1990) 3.30
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J (1990) 3.21
Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev (1990) 3.18
Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J (1990) 3.16
Transcription of T cell receptor beta-chain genes is controlled by a downstream regulatory element. EMBO J (1988) 2.93
A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol Cell Biol (1990) 2.90
lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell (1989) 2.84
Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A (1989) 2.45
Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science (1990) 2.40
Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J (1990) 2.38
The expression of three members of the achaete-scute gene complex correlates with neuroblast segregation in Drosophila. Cell (1987) 2.29
A T cell-specific transcriptional enhancer within the human T cell receptor delta locus. Science (1990) 2.09
Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer (1990) 1.85
Differentiation-linked leukemogenesis in lymphocytes. Science (1986) 1.68
Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med (1990) 1.39
The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol (1990) 1.38
The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood (1990) 1.36
Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron. J Exp Med (1990) 1.22
Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression. Proc Natl Acad Sci U S A (1989) 1.10
T cell receptor beta gene has two downstream DNase I hypersensitive regions. Possible mechanisms of tissue- and stage-specific gene regulation. J Exp Med (1989) 0.90
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet (1996) 12.96
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature (2001) 7.31
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science (2000) 5.62
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature (1984) 4.24
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol (2011) 4.22
The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J Biol Chem (1998) 3.67
Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature (1984) 3.48
Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups. Cell (1986) 3.41
The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet (1996) 3.35
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J (1990) 3.21
The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J (1988) 2.81
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
Gallbladder muscle dysfunction in patients with chronic acalculous disease. Gastroenterology (2001) 2.73
Do rehabilitative nursing homes improve the outcomes of care? J Am Geriatr Soc (1996) 2.63
Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science (2001) 2.50
Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J (1990) 2.38
Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology (2005) 2.33
The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet (2004) 2.33
Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J (1994) 2.32
Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol (2000) 2.32
Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J Biol Chem (2001) 2.27
Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci (2001) 2.16
Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med (1999) 2.11
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J (1996) 2.11
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci U S A (1994) 2.09
Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int (1989) 2.04
Sequence analysis and in vitro transcription of portions of the Epstein-Barr virus genome. J Cell Biochem (1982) 2.02
Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem (2000) 2.02
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol (1994) 2.00
Substrate deformation levels associated with routine physical activity are less stimulatory to bone cells relative to loading-induced oscillatory fluid flow. J Biomech Eng (2000) 1.96
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors. Cell (1985) 1.87
Present-day crustal deformation in China constrained by global positioning system measurements. Science (2001) 1.87
Rainforest aerosols as biogenic nuclei of clouds and precipitation in the Amazon. Science (2010) 1.86
Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor. J Biol Chem (2000) 1.86
Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol (1997) 1.78
Cell anchorage permits efficient signal transduction between ras and its downstream kinases. J Biol Chem (1997) 1.75
Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet (1996) 1.74
Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun (2001) 1.72
IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest (2000) 1.66
GFI1B mutation causes a bleeding disorder with abnormal platelet function. J Thromb Haemost (2013) 1.66
High-resolution soft X-ray beamline ADRESS at the Swiss Light Source for resonant inelastic X-ray scattering and angle-resolved photoelectron spectroscopies. J Synchrotron Radiat (2010) 1.66
Synaptonemal complex antigen location and conservation. J Cell Biol (1987) 1.65
Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. J Biol Chem (1998) 1.64
Intramural mechanics of the human tongue in association with physiological deformations. J Biomech (1999) 1.63
Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol (1994) 1.62
Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol Sci (1995) 1.62
A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J Biol Chem (2000) 1.62
Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. Vaccine (2003) 1.61
PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. Ann Oncol (2011) 1.61
Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J Neurosci (1996) 1.60
Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res (1991) 1.59
A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 alpha subunit. Implications for the endocytic pathway. J Biol Chem (1996) 1.58
Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc Natl Acad Sci U S A (1994) 1.57
Sensitivity analyses including and excluding the HWE-violating studies are required for meta-analyses of genetic association studies. Breast Cancer Res Treat (2009) 1.56
Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are a manifestation of partial status epilepticus. Epilepsia (1994) 1.53
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Terminal repetitive sequences in herpesvirus saimiri virion DNA. J Virol (1985) 1.51
Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5'-triphosphate. Biochemistry (1996) 1.51
Turbo spin-echo diffusion-weighted MR of ischemic stroke. AJNR Am J Neuroradiol (1998) 1.50
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol (2000) 1.50
Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys (2000) 1.49
Abnormalities of gallbladder muscle associated with acute inflammation in guinea pigs. Am J Physiol Gastrointest Liver Physiol (2001) 1.48
The incremental direct costs associated with behavioral symptoms in AD. Neurology (2002) 1.48
Revision surgery for lumbar disc herniation. An analysis of 45 patients. Int Orthop (1995) 1.48
Treatment with low-dose aspirin increased the level LIF and integrin β3 expression in mice during the implantation window. Placenta (2010) 1.46
The optimal outcomes of post-hospital care under medicare. Health Serv Res (2000) 1.46
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci U S A (1997) 1.46
The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2009) 1.45
Effect of Cr(VI) exposure on sperm quality: human and animal studies. Ann Occup Hyg (2001) 1.45
The mechanism of chromosome 14 inversion in a human T cell lymphoma. Cell (1987) 1.44
New hypothesis of chronic back pain: low pH promotes nerve ingrowth into damaged intervertebral disks. Acta Anaesthesiol Scand (2012) 1.43
Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci U S A (1994) 1.42
Use of post-hospital care by Medicare patients. J Am Geriatr Soc (1996) 1.41
Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ (2012) 1.41
Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ (2010) 1.41
Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma. Nature (1984) 1.41
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res (2001) 1.40
Interstitial photodynamic therapy in the canine prostate. Br J Urol (1997) 1.40
Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med (1990) 1.39
Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol (1999) 1.39
Clinical application of free digital artery flap of the hand. Plast Reconstr Surg (1999) 1.39
Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood (1995) 1.38
Granular cell tumor of the sinus node. Am J Cardiol (1993) 1.37
Evidence for direct interaction between Sprouty and Cbl. J Biol Chem (2000) 1.37
Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene (1993) 1.36
Elemental analysis of renal slices by proton-induced X-ray emission. Environ Health Perspect (1993) 1.35
Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China. Sex Transm Infect (2006) 1.34
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther (2001) 1.34
Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav (1994) 1.33
Human T-cell tumours containing chromosome 14 inversion or translocation with breakpoints proximal to immunoglobulin joining regions at 14q32. EMBO J (1987) 1.32